Joana Magno, MD
Cardiovascular Disease · Honolulu, HINPI 1447266655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $20,569 of the $23,008 with a category attached, or 89.4%. It is spread thinly across 34 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $5,708 and has fallen 70.2% since, to $1,700 in 2025. Among cardiovascular disease clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 444 payments — averaging $51.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$4K
- Abiomed$3K
- Abbott$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- Johnson & Johnson$2K
- Shockwave Medical, Inc$2K
- plus $9K from 28 others
What the payments were for
- Travel & lodging$2,41410%
- Food & beverage$20,56989%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 22 | $4,207 |
| Abiomed | 35 | $3,385 |
| Abbott | 24 | $1,989 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 51 | $1,632 |
| Johnson & Johnson | 65 | $1,562 |
| Shockwave Medical, Inc | 16 | $1,545 |
| Boston Scientific | 30 | $1,352 |
| AstraZeneca | 32 | $927 |
| Impulse Dynamics (USA) Inc. | 4 | $572 |
| Inari Medical, Inc. | 6 | $560 |
| Boehringer Ingelheim | 22 | $553 |
| Bayer | 13 | $507 |
| Novo Nordisk | 8 | $459 |
| Novartis | 27 | $434 |
| Amarin Pharma, Inc. | 12 | $383 |
| E.r. Squibb & Sons, L.L.C. | 9 | $380 |
| Esperion Therapeutics, Inc. | 10 | $365 |
| Teleflex LLC | 3 | $341 |
| Amgen | 14 | $329 |
| Merck | 10 | $239 |
| Philips North America LLC | 2 | $220 |
| Regeneron Healthcare Solutions, Inc. | 8 | $168 |
| Heartflow, Inc. | 1 | $166 |
| Atricure, Inc. | 1 | $149 |
| Medtronic | 2 | $134 |
| Sanofi-aventis U.S. LLC | 5 | $120 |
| Pfizer | 3 | $79 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $63 |
| Kowa Pharmaceuticals America, Inc. | 1 | $51 |
| Gilead | 2 | $42 |
| Baxter Healthcare | 1 | $30 |
| Dexcom, Inc. | 1 | $25 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$2,243
- OPTIMIZER$644
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$609
- XARELTO$585
- FLOWTRIEVER CATHETER, S$507
- CT THROMBECTOMY SYSTEM KIT$507
- JOT DX$398
- LifeVest$373
- Ozempic$369
- Vascular Lithotripsy$331
- GUIDELINER$262
- NEXLIZET$240
- NEXLETOL$240
- (5044) MCOT$220
- Kerendia$206
- Fortify Assura, Ellipse ICD$180
- OPTIMIZER SMART SYSTEM$180
- MitraClip$170
- FFRct$166
- AVEIR$158
How this compares
$23,008 in reported general payments places this provider in the 95th percentile of 73 cardiovascular disease providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 344 | $403,942 |
| XareltoRivaroxaban | 156 | $194,909 |
| EntrestoSacubitril/Valsartan | 98 | $149,052 |
| JardianceEmpagliflozin | 37 | $48,149 |
| BrilintaTicagrelor | 39 | $39,051 |
| Repatha SureclickEvolocumab | 22 | $16,321 |
| Atorvastatin Calcium | 495 | $12,345 |
| Metoprolol Succinate | 615 | $9,695 |
| Rosuvastatin Calcium | 139 | $6,794 |
| Ranolazine ErRanolazine | 26 | $4,599 |
| ClopidogrelClopidogrel Bisulfate | 217 | $4,335 |
| Losartan Potassium | 282 | $4,004 |
| Flecainide Acetate | 49 | $3,161 |
| Amlodipine Besylate | 193 | $2,492 |
| Valsartan | 57 | $2,406 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $79 | $403,942344 claims |
| Johnson & JohnsonXarelto | $1,562 | $194,909156 claims |
| NovartisEntresto | $434 | $149,05298 claims |
| Boehringer IngelheimJardiance | $553 | $48,14937 claims |
| AstraZenecaBrilinta | $927 | $39,05139 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 73 cardiovascular disease providers in Hawaii.
Other cardiovascular disease in Honolulu
- Dipanjan BanerjeeHonolulu$331K
- Hingson ChunHonolulu$23K
- William DangHonolulu$16K
- Edward ShenHonolulu$12K
- Se Kon WonHonolulu$11K
- Wesley KaiHonolulu$10K
- Calvin WongHonolulu$8K
- Abdulelah NuqaliHonolulu$7K
- Mahdi Veillet-ChowdhuryHonolulu$7K
- Nath LimpruttidhamHonolulu$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.